Why 50+ People Should Get Vaccinated Against Shingles
Extremely promising new herpes vaccine moves closer to human trials
A new herpes vaccine leaves no trace of infection or disease | Penn Today
From foundational discoveries to profound impact | Penn Today
From foundational discoveries to profound impact | Penn Today
Dr. Drew Weissman on the exciting future of mRNA | Christie's
Cureus | Hypertrophic Perianal Herpes Mimicking Squamous Cell Cancer: A Case Report and a Review of the Literature
Messenger RNA vaccines: Now proven against coronavirus, the technology can do so much more | CNN
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection | PLOS Pathogens
New HSV-2 Vaccine Uses mRNA to Treat Herpes in Mice | Penn Medicine
New Genital Herpes Vaccine Candidate Provides Powerful Protection in Preclinical Tests - Penn Medicine
mRNA Vaccines: A Bright Future in Vaccinology | Penn Medicine
Genital Herpes Vaccine Is a Winner in Animals. Next Up: Testing on Humans - Be part of the knowledge - ReachMD
Shingles Vaccine and IBD Research at Penn - Penn Medicine
Laying the Groundwork for COVID-19 Vaccines: Dr. Drew Weissman and mRNA Technology at Penn Medicine - YouTube
mRNA: Technology used to make Pfizer, Moderna COVID vaccines tested to treat HIV, cancer, more - 6abc Philadelphia
Penn Medicine researchers develop vaccine for genital herpes | The Daily Pennsylvanian
Penn's genital herpes vaccine is a winner in animals. Next up: Testing on humans.
How vaccines may affect the cornea - EyeWorld
mRNA Vaccines for Infectious Diseases Beyond COVID-19 | Penn Medicine
Harvey M. Friedman | Faculty | About Us | Perelman School of Medicine | Perelman School of Medicine at the University of Pennsylvania
Genital Herpes News, Research
:max_bytes(150000):strip_icc()/FDA-Planning-to-Warn-of-Guillain-Barre-Syndrome-Linked-to-Johnson-Johnson-Vaccine-GettyImages-515388300-1164571016--2000-874ab2ab9da9409688e03478896e6287.jpg "J&J COVID Vaccine Linked to Guillain-Barré Syndrome")
J&J COVID Vaccine Linked to Guillain-Barré Syndrome
